Skip to Main Content

Pfizer Inc.

PFE Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

$PFE stock is featured in our Dan Meuser, Rob Bresnahan, and Sector Weighted DC Insider strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of PFE by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Sale $1,001 - $15,000 Sep 15, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 15, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 15, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 05, 2025
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Aug 05, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jul 16, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 01, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 20, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 20, 2025
Ron Wyden Senate / D Sale (Full) $1,001 - $15,000 Jun 03, 2025
Josh Gottheimer House / D Sale $1,001 - $15,000 Jun 03, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 May 30, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 May 28, 2025
Ro Khanna House / D Purchase $15,001 - $50,000 May 19, 2025
Robert Bresnahan House / R Purchase $15,001 - $50,000 May 15, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Apr 29, 2025
Bruce Westerman House / R Sale $1,001 - $15,000 Apr 21, 2025
Ro Khanna House / D Sale $15,001 - $50,000 Apr 15, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 Apr 11, 2025
Ro Khanna House / D Sale $15,001 - $50,000 Apr 09, 2025
Robert Bresnahan House / R Sale $15,001 - $50,000 Apr 08, 2025
Gilbert Ray Cisneros, Jr. House / D Sale $15,001 - $50,000 Mar 31, 2025
Carol D. Miller House / R Sale $1,001 - $15,000 Mar 10, 2025
Bruce Westerman House / R Purchase $1,001 - $15,000 Mar 03, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Feb 26, 2025
Robert Bresnahan House / R Purchase $15,001 - $50,000 Feb 25, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 Feb 24, 2025
John Boozman Senate / R Sale (Full) $1,001 - $15,000 Feb 13, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Feb 12, 2025
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Jan 24, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 22, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Jan 15, 2025
Ro Khanna House / D Sale $15,001 - $50,000 Nov 15, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 13, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 13, 2024
Laurel M. Lee House / R Purchase $15,001 - $50,000 Oct 21, 2024
Greg Landsman House / D Sale $1,001 - $15,000 Oct 15, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 27, 2024
Kathy E. Manning House / D Sale $1,001 - $15,000 Aug 09, 2024
C. Scott Franklin House / R Sale $15,001 - $50,000 Aug 06, 2024
C. Scott Franklin House / R Sale $1,001 - $15,000 Aug 01, 2024
Ro Khanna House / D Purchase $15,001 - $50,000 May 29, 2024
Tommy Tuberville Senate / R Sale (Full) $15,001 - $50,000 May 03, 2024
Ro Khanna House / D None $15,001 - $50,000 Apr 26, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 23, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 25, 2024
PFE Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
PFE Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
PFE Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in PFE holdings by institutional investors

Quarterly net insider trading by PFE's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $3,730,000 Oct 20, 2025 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $2,730,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $4,240,000 Apr 21, 2025 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,600,000 Mar 21, 2025 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $3,740,000 Mar 21, 2025 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,070,000 Dec 11, 2024 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,450,000 Jul 19, 2024 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $3,000,000 Jan 19, 2024 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $4,050,000 Oct 20, 2023 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,480,000 Jul 20, 2023 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $3,050,000 Jan 20, 2023 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $3,250,000 Oct 20, 2022 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $3,480,000 Sep 02, 2022 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $3,820,000 Sep 02, 2022 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $2,980,000 Jan 20, 2022 Issue: Health Issues Medicare/Medicaid Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,780,000 Oct 20, 2021 Issue: Medicare/Medicaid Trade (domestic/foreign) Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $2,330,000 Jul 20, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $3,160,000 Apr 15, 2021 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid
  • $2,380,000 Jan 21, 2021 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Medicare/Medicaid
  • $1,930,000 Oct 20, 2020 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $2,470,000 Jul 20, 2020 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
  • $4,090,000 Apr 20, 2020 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid Budget/Appropriations
  • $2,300,000 Jan 31, 2020 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations
  • $1,650,000 Oct 22, 2019 Issue: Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $2,870,000 Jul 22, 2019 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues
  • $4,180,000 Jul 19, 2019 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $2,020,000 Apr 13, 2019 Issue: Budget/Appropriations Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $2,780,000 Oct 21, 2018 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Alcohol and Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
  • $1,950,000 Oct 21, 2018 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Alcohol and Drug Abuse Medicare/Medicaid Budget/Appropriations
  • $4,650,000 Apr 20, 2018 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations Alcohol and Drug Abuse Taxation/Internal Revenue Code
  • $1,920,000 Jan 22, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Alcohol and Drug Abuse
  • $2,820,000 Oct 20, 2017 Issue: Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Alcohol and Drug Abuse Copyright/Patent/Trademark Health Issues Budget/Appropriations
  • $3,790,000 Aug 03, 2017 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Alcohol and Drug Abuse Medicare/Medicaid Budget/Appropriations Copyright/Patent/Trademark Health Issues
  • $2,110,000 Aug 03, 2017 Issue: Budget/Appropriations Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark Alcohol and Drug Abuse Taxation/Internal Revenue Code Medicare/Medicaid
  • $2,820,000 Jul 25, 2017 Issue: Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Alcohol and Drug Abuse Health Issues
  • $2,790,000 Oct 21, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Alcohol and Drug Abuse Taxation/Internal Revenue Code
  • $1,620,000 Oct 20, 2016 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Alcohol and Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
  • $3,280,000 Apr 20, 2016 Issue: Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid Copyright/Patent/Trademark
  • $2,110,000 Jan 20, 2016 Issue: Trade (domestic/foreign) Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $2,380,000 Dec 16, 2015 Issue: Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products Medicare/Medicaid Alcohol and Drug Abuse
  • $1,750,000 Jul 21, 2015 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Consumer Issues/Safety/Products Medicare/Medicaid Copyright/Patent/Trademark Alcohol and Drug Abuse
  • $3,160,000 Apr 21, 2015 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Alcohol and Drug Abuse
  • $1,460,000 Jan 21, 2015 Issue: Trade (domestic/foreign) Consumer Issues/Safety/Products Medicare/Medicaid Alcohol and Drug Abuse Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $2,100,000 Oct 20, 2014 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $1,620,000 Jul 21, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products Trade (domestic/foreign) Alcohol and Drug Abuse
  • $3,190,000 Apr 21, 2014 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Alcohol and Drug Abuse Copyright/Patent/Trademark Health Issues
  • $2,090,000 Jan 21, 2014 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Alcohol and Drug Abuse Trade (domestic/foreign) Health Issues
  • $2,380,000 Oct 18, 2013 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Alcohol and Drug Abuse Taxation/Internal Revenue Code Consumer Issues/Safety/Products Trade (domestic/foreign)
  • $1,530,000 Jul 19, 2013 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign) Alcohol and Drug Abuse
  • $2,890,000 May 01, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Consumer Issues/Safety/Products Trade (domestic/foreign) Alcohol and Drug Abuse
  • $1,730,000 Jan 22, 2013 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Copyright/Patent/Trademark Defense Trade (domestic/foreign) Alcohol and Drug Abuse Animals
  • $2,600,000 Oct 22, 2012 Issue: Animals Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Defense Trade (domestic/foreign) Copyright/Patent/Trademark Alcohol and Drug Abuse
  • $2,330,000 Jul 20, 2012 Issue: Animals Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Alcohol and Drug Abuse Defense Copyright/Patent/Trademark Trade (domestic/foreign)
  • $3,550,000 May 25, 2012 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products Medicare/Medicaid Alcohol and Drug Abuse Defense Trade (domestic/foreign) Animals
  • $1,730,000 May 25, 2012 Issue: Consumer Issues/Safety/Products Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
  • $3,360,000 Oct 20, 2011 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $3,550,000 Jul 19, 2011 Issue: Consumer Issues/Safety/Products Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Copyright/Patent/Trademark Trade (domestic/foreign)
  • $3,790,000 Apr 20, 2011 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $2,590,000 Jan 20, 2011 Issue: Health Issues Trade (domestic/foreign) Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products
  • $4,150,000 Oct 20, 2010 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $6,200,000 Sep 21, 2010 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Agriculture Trade (domestic/foreign) Defense Budget/Appropriations Labor Issues/Antitrust/Workplace
  • $5,860,000 Sep 21, 2010 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Agriculture Defense Environment/Superfund
  • $2,250,000 Jul 20, 2010 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Defense Trade (domestic/foreign) Copyright/Patent/Trademark
  • $5,420,000 Oct 20, 2009 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Defense Agriculture
  • $5,340,000 Oct 20, 2009 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Defense Environment/Superfund Agriculture
  • $5,580,000 Jul 20, 2009 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Trade (domestic/foreign) Taxation/Internal Revenue Code Defense Labor Issues/Antitrust/Workplace
  • $3,250,000 Jan 21, 2009 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Agriculture Trade (domestic/foreign) Torts Environment/Superfund Defense
  • $3,070,000 Oct 27, 2008 Issue: Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Defense Trade (domestic/foreign) Consumer Issues/Safety/Products Agriculture Torts
  • $3,060,000 Jul 21, 2008 Issue: Torts Consumer Issues/Safety/Products Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Agriculture Defense Taxation/Internal Revenue Code
  • $2,800,000 Apr 21, 2008 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Consumer Issues/Safety/Products Taxation/Internal Revenue Code Defense Environment/Superfund Agriculture
  • $6,580,000 Feb 14, 2008 Issue: Budget/Appropriations Agriculture Trade (domestic/foreign) Science/Technology Consumer Issues/Safety/Products Environment/Superfund Copyright/Patent/Trademark Defense Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $7,220,000 Aug 14, 2007 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Defense Trade (domestic/foreign) Budget/Appropriations Science/Technology Environment/Superfund
  • $5,800,000 Apr 27, 2007 Issue: Science/Technology Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Trade (domestic/foreign) Environment/Superfund Animals Torts
  • $4,500,000 Aug 14, 2006 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Consumer Issues/Safety/Products Animals Torts Medicare/Medicaid Budget/Appropriations Science/Technology
  • $3,490,000 Feb 14, 2006 Issue: Budget/Appropriations Medicare/Medicaid Consumer Issues/Safety/Products Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Agriculture Taxation/Internal Revenue Code Torts Science/Technology Animals
  • $3,000,000 Aug 15, 2005 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products Torts Science/Technology
  • $2,660,000 Feb 14, 2005 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products Torts Science/Technology
  • $3,000,000 Aug 16, 2004 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Torts Science/Technology Budget/Appropriations Consumer Issues/Safety/Products
  • $1,880,000 Feb 17, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products Torts Science/Technology Agriculture
  • $1,840,000 Aug 14, 2003 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Science/Technology Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products Torts
  • $1,700,000 Feb 14, 2003 Issue: Agriculture Copyright/Patent/Trademark Health Issues Budget/Appropriations Consumer Issues/Safety/Products
  • $90,000 Aug 14, 2002 Issue: Taxation/Internal Revenue Code
  • $1,900,000 Aug 14, 2002 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Science/Technology Consumer Issues/Safety/Products Budget/Appropriations Agriculture Trade (domestic/foreign) Health Issues Medicare/Medicaid
  • $60,000 Jun 25, 2002 Issue: Medicare/Medicaid Pharmacy
  • $60,000 Mar 12, 2002 Issue: Trade (domestic/foreign)
  • $40,000 Mar 05, 2002 Issue: Health Issues Medicare/Medicaid
  • $60,000 Mar 01, 2002 Issue: Trade (domestic/foreign) Aviation/Airlines/Airports Pharmacy Consumer Issues/Safety/Products
  • $20,000 Feb 14, 2002 Issue: Medicare/Medicaid
  • $40,000 Feb 14, 2002 Issue: Trade (domestic/foreign) Health Issues Taxation/Internal Revenue Code
  • $120,000 Feb 14, 2002 Issue: Transportation Health Issues
  • $20,000 Feb 12, 2002 Issue: Trade (domestic/foreign) Health Issues
  • $100,000 Jan 29, 2002 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid
  • $30,000 Jan 17, 2002 Issue: None
  • $1,840,000 Aug 14, 2001 Issue: Trade (domestic/foreign) Agriculture Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products
  • $1,800,000 Feb 14, 2001 Issue: Transportation Trade (domestic/foreign) Financial Institutions/Investments/Securities Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Animals
  • $1,640,000 Aug 14, 2000 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Financial Institutions/Investments/Securities Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Agriculture Transportation
  • $1,880,000 Feb 14, 2000 Issue: Transportation Taxation/Internal Revenue Code Trade (domestic/foreign) Financial Institutions/Investments/Securities Agriculture Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products
  • $1,950,000 Aug 16, 1999 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Agriculture Transportation Health Issues Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products

PFE Estimated quarterly lobbying spending

PFE Revenue by Segment or Geography

By Segment
By Geography
PFE Income Statement
PFE Balance Sheet
PFE Cash Flow
U.S. Patents

New PFE patent grants

  • Patent Title: Blister pack pill tray Jul. 07, 2020
  • Patent Title: Blister pack pill tray Jul. 07, 2020
  • Patent Title: Pill blister pack Jul. 07, 2020
  • Patent Title: Pill blister pack Jul. 07, 2020
  • Patent Title: Therapeutic wrap Oct. 29, 2019
  • Patent Title: Therapeutic wrap Oct. 29, 2019
  • Patent Title: Antibody to gdf8 and uses thereof Dec. 26, 2017
  • Patent Title: Heteroaromatic compounds and their use as dopamine d1 ligands Dec. 26, 2017
  • Patent Title: 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors Dec. 19, 2017
  • Patent Title: High throughput fabrication of nanoparticles Dec. 19, 2017
  • Patent Title: Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers Dec. 05, 2017
  • Patent Title: Anti-il-13 receptor alpha 2 antibodies and antibody-drug conjugates Nov. 28, 2017
  • Patent Title: Heteroaromatic compounds and their use as dopamine d1 ligands Nov. 21, 2017
  • Patent Title: Azabenzimidazole compounds Nov. 14, 2017
  • Patent Title: Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Nov. 07, 2017
  • Patent Title: Immunogenic fusion polypeptides Oct. 31, 2017
  • Patent Title: Imidazopyridazine derivatives as modulators of the gabaa receptor activity Oct. 31, 2017
  • Patent Title: Diacylglycerol acyltransferase 2 inhibitors Oct. 17, 2017
  • Patent Title: Saccharides and uses thereof Oct. 03, 2017
  • Patent Title: Anti-ptk7 antibody-drug conjugates Oct. 03, 2017
  • Patent Title: N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]oxazin-8a(8h)-yl)-thiazol-4-yl) amides Sep. 26, 2017
  • Patent Title: 2-thiopyrimidinones Sep. 26, 2017
  • Patent Title: Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole Sep. 26, 2017
  • Patent Title: Cyclopropabenzofuranyl pyridopyrazinediones Sep. 19, 2017
  • Patent Title: Spliceostatin analogs and methods for their preparation Sep. 19, 2017
  • Patent Title: Pyrimidine derivatives Sep. 12, 2017
  • Patent Title: Fxa variant compositions Sep. 12, 2017
  • Patent Title: Antagonist antibodies against gdf-8 and uses therefor Sep. 05, 2017
  • Patent Title: N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl)-1,3-thiazol-4-yl]amides Sep. 05, 2017
  • Patent Title: Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders Sep. 05, 2017
  • Patent Title: Celecoxib compositions Sep. 05, 2017
  • Patent Title: Heterocyclic compounds and their use as dopamine d1 ligands Aug. 29, 2017
  • Patent Title: 2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides Aug. 29, 2017
  • Patent Title: Enhanced stability of novel liquid compositions Aug. 29, 2017
  • Patent Title: Antagonists of prostaglandin ep3 receptor Aug. 22, 2017
  • Patent Title: Anti-cxcr4 antibodies and antibody-drug conjugates Jul. 18, 2017
  • Patent Title: 3,4-disubstituted-1 h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors Jul. 04, 2017
  • Patent Title: Heteroaromatic compounds and their use as dopamine d1 ligands Jun. 27, 2017
  • Patent Title: Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof Jun. 20, 2017
  • Patent Title: Engineered polypeptide conjugates and methods for making thereof using transglutaminase Jun. 13, 2017
  • Patent Title: Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof Jun. 06, 2017
  • Patent Title: Solid molecular dispersion of fesoterodine hydrogen fumarate and polymeric binder Jun. 06, 2017
  • Patent Title: Aminopyrimidinyl compounds May. 30, 2017
  • Patent Title: Combination of inotuzumab ozogamicin and torisel for the treatment of cancer May. 09, 2017
  • Patent Title: Substituted pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors May. 09, 2017
  • Patent Title: Solid forms of a macrocyclic kinase inhibitor May. 02, 2017
  • Patent Title: Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic-acid May. 02, 2017
  • Patent Title: Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr Apr. 11, 2017
  • Patent Title: Antibodies to madcam Jan. 19, 2016
  • Patent Title: Pyrrolo[2,3-d]pyrimidine compounds Sep. 28, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to PFE from public contracts

PFE News

Recent insights relating to PFE

CNBC Recommendations

Recent picks made for PFE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PFE

PFE Analyst Ratings

PFE Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
PFE Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $PFE stock a Buy, Sell, or Hold?

  • What is the price target for $PFE stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

PFE Top Shareholders
Shareholder
Shares Held
PFE Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $PFE stock?

  • Who owns the most shares of $PFE stock?

  • What funds own $PFE stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

PFE Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view PFE Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About PFE

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

  • Address New York, NY
  • Market Cap 142.4 billion
  • Employees 81,000
  • Industrial Classification Pharmaceutical Preparations
Back To Top